TGT 10-K Analysis: Why Target's Dividend Math No Longer Works

Target Corporation, the $105 billion general merchandise retailer operating approximately 2,000 stores with 57 consecutive years of dividend increases, reported its SG&A rate as "flat" in FY2025. The 10-K tells a different story: a $593 million interchange fee settlement masked a 30 basis point deterioration in the underlying cost base, and adjusted operating income declined 14.2% — nearly twice the reported 8.1% GAAP decline.

The headline numbers present a company in a controlled deceleration. Revenue dipped 1.7% to $104.8 billion on negative 2.6% comparable store sales. GAAP EPS came in at $8.13 on operating cash flow of $6.56 billion. Management declared its 57th consecutive dividend increase and called capital allocation "disciplined." At $105.47 per share, the stock offers a 4.3% yield and trades at 6.9x EV/EBITDA — optically cheap for a blue-chip retailer.

But the FY2025 10-K reveals structural fractures beneath the familiar narrative. Management's own $5 billion FY2026 capex guide pushes projected free cash flow to roughly $1.56 billion — $538 million below the annual dividend. Gross debt increased $494 million even as management described capital allocation as disciplined. And a $250 million business transformation effort is underway with costs that management says it "cannot reasonably estimate." The question facing income investors is no longer whether Target can grow, but whether it can continue to fund the dividend streak that defines its identity — without borrowing to do it.

The Cost Illusion: How a $593M Settlement Hid a 14.2% Operating Income Decline

Target's reported earnings quality is materially lower than headlines suggest. A one-time litigation settlement and an open-ended transformation program combine to distort the underlying cost trajectory — and FY2026 has no comparable windfall to fill the gap.

The core issue is straightforward. Target reported its SG&A expense rate as "consistent with 2024" at 20.6%. That statement is technically accurate on a GAAP basis. But the filing's own adjusted disclosure reveals a different reality.

"Our SG&A expense rate was 20.6 percent in 2025, consistent with 2024. The 2025 rate included a 0.6 percentage point benefit from interchange fee settlements, partially offset by 0.2 percentage points of business transformation costs. Excluding these items, our Adjusted SG&A expense rate was 20.9 percent in 2025, compared with 20.6 percent in 2024, reflecting the deleveraging impact of lower Net Sales and the net impact of other costs."

The $593 million interchange fee settlement contributed approximately $1.01 per share after tax . Strip that benefit and add back the $250 million in transformation costs, and the adjusted picture deteriorates sharply.

The gap between GAAP and adjusted operating income growth — 8.1% versus 14.2% — is the single most important number in this filing for earnings-focused investors. It means 6.9% of reported EPS was non-recurring. And the structural cost pressures are accelerating: self-insurance accruals jumped 14% from $772 million to $881 million, adding a $109 million headwind that reflects rising labor and claims costs, not a one-time event.

Meanwhile, the $250 million in business transformation costs comes with no ceiling. The filing's risk factors section warns that Target "cannot reasonably estimate" the amount of future transformation charges. This is not a standard restructuring with a defined endpoint — it is an open-ended program to "increase speed and agility across the organization" that management acknowledges "may continue to require significant changes to the day-to-day ways of working."

For FY2026, Target guides EPS of $7.50 to $8.50. At the midpoint of $8.00, the company needs approximately $1.01 per share in organic operating improvement just to replace the interchange settlement benefit before delivering any actual growth. Target Corporation's adjusted operating income declined 14.2% in FY2025, nearly twice the 8.1% GAAP decline, after a $593 million interchange fee settlement masked the worst SG&A deleverage in three years.

The Capital Return Breaking Point: Three Cash Claims vs. One Cash Source

Target's capital return model is structurally breaking. Three non-deferrable cash demands simultaneously exceed operating cash flow, transforming a 57-year dividend aristocrat into a borrowing-dependent income play.

Standard free cash flow analysis paints a tight but manageable picture. FY2025 FCF of $2.84 billion covers the $2.10 billion dividend at 1.35x. But this framing misses two additional demands on the same cash pool: the $5 billion capex program that management has guided for FY2026, and $2.13 billion in debt maturing within 12 months. When all three claims hit simultaneously, the math breaks.

"We expect capital expenditures in 2026 of approximately $5 billion to support our store experience and remodel program, continued investment in supply chain and technology projects, and investment in new stores."

The $2.67 billion deficit is manageable in the near term — Target holds $5.49 billion in cash and has a $3.0 billion undrawn revolving credit facility expiring October 2028. But it marks a paradigm shift. For the first time in 57 years of consecutive dividend increases, the dividend cannot be funded from operating cash flow at the company's own guided investment pace. Target has transitioned from "generate and distribute" to "borrow and distribute."

The capital return compression is visible across every metric. FCF payout ratio jumped from 46.4% to 73.9%. Buybacks were slashed 59.5%, from $1.01 billion to $408 million. Dividend growth hit a 57-year low at just 1.8%. And after-tax ROIC — the ultimate measure of whether invested capital is creating value — declined 160 basis points from 15.4% to 13.8% while average invested capital grew $1.19 billion to $30.4 billion. Target is spending more while earning less.

The balance sheet tells the same story. Gross debt increased $494 million to $14.4 billion, contradicting the disciplined capital allocation narrative. As cheap legacy debt at a 2.9% average rate (2026-2030 maturity bucket) rolls off and is replaced at 4.5-5.0%, Target faces an incremental annual interest expense headwind of roughly $80-103 million — approximately $0.17 per share after tax. The filing discloses that covenants "have no practical effect on our ability to pay dividends," but the economic constraint is cash flow, not covenants. Target's projected FY2026 free cash flow of $1.56 billion falls $538 million below its annual dividend commitment, forcing the 57-year dividend aristocrat to borrow to sustain shareholder payments for the first time.

The Private-Label Tariff Trap: When Differentiation Becomes Vulnerability

Target's competitive advantage — 45 or more owned and exclusive brands representing approximately 30% of merchandise sales — is simultaneously its greatest tariff vulnerability. Private labels carry concentrated international sourcing risk, amplified by a previously underappreciated customs program that the filing identifies as a material risk factor.

The exposure is substantial. Approximately $31.4 billion in annual owned-brand revenue depends on supply chains that the filing describes in plain terms.

"Approximately one-half of the merchandise that we offer is sourced, directly or indirectly, from outside the U.S., with China as our single largest source of merchandise we import."

National brands can shift tariff costs to their own margins or spread them across multiple retail channels. But Target's owned brands — which "generally carry higher margins than equivalent national brand products," per the filing — have no such buffer. Target controls the full supply chain from sourcing to shelf, which means it absorbs the full tariff impact on its highest-margin products.

The risk is compounded by the First Sale Declaration Program, a customs methodology that most investors have likely never encountered in a retail 10-K.

"We also utilize a first sale declaration program... to pay duties and tariffs to U.S. Customs for merchandise on the basis of the price paid by our vendors rather than the price paid by the importer of record. Our program may be subject to inquiries, investigations, or regulatory proceedings by U.S. Customs. The amount of duties and tariffs that we pay to import merchandise could rise substantially if the U.S. government eliminates the availability of the first sale declaration methodology."

Under this program, Target pays import duties based on the vendor's manufacturing cost — a lower figure — rather than Target's actual purchase price. If U.S. Customs eliminates this methodology, duties would be assessed on a "substantially higher cost basis." The dollar impact is not quantified in the filing, but for a company importing roughly half of $104.8 billion in merchandise, even a small percentage-point increase in effective duty rates translates to hundreds of millions in additional costs.

The most telling detail is what the guidance excludes. Management's FY2026 EPS range of $7.50-$8.50 assumes approximately 2% revenue growth and a 4.8% operating margin — but explicitly states it cannot reasonably estimate tariff costs. This means the guidance range does not account for what the filing itself identifies as a material risk. Target's 45 owned brands — representing approximately $31.4 billion in annual merchandise sales — face concentrated tariff exposure because approximately half of all merchandise is sourced internationally with China as the single largest source country.

The Floor Under Earnings: Shrink Recovery, Fulfillment Efficiency, and Why They Are Not Enough

Two genuine operational wins provide a real floor under Target's earnings — but both are largely one-time improvements that have already been captured, making them insufficient to offset the structural pressures documented in the preceding sections.

The first bright spot is inventory shrink. The filing discloses that Target achieved "significant improvements in inventory shrink throughout the year, with shrink rates reaching pre-pandemic levels." The quantification comes from a sensitivity disclosure that most analysts overlook.

"A 10 percent increase or decrease in our 2025 year-end inventory shrink reserve would impact our cost of sales by approximately $110 million. Historically, our actual physical inventory count results have shown our estimates to be reasonably accurate."

A $110 million impact from a 10% change implies a total shrink reserve of approximately $1.1 billion . That the reserve has declined to pre-pandemic levels from its elevated post-2020 peak represents a meaningful gross margin tailwind. However, this improvement is inherently non-recurring — shrink cannot reach pre-pandemic levels twice. The ongoing benefit is maintaining the lower rate, not achieving further reductions.

The second bright spot is supply chain efficiency. Despite ongoing growth in digital fulfillment volume, supply chain and digital fulfillment costs declined $87 million from $7,618 million to $7,531 million. This is the first quantified evidence consistent with Target's store-as-hub fulfillment strategy, where over 95% of digital orders ship from stores with two-thirds fulfilled via same-day options.

The caveat is in the rate. While absolute supply chain costs declined, the rate as a percentage of revenue edged up 4 basis points — from 7.15% to 7.19% — reflecting volume deleverage on the 1.7% revenue decline. The efficiency gains are real but are partly offsetting the mathematical headwind of declining same-store sales, not overcoming it. Target's inventory shrink reserve of approximately $1.1 billion reached pre-pandemic levels while supply chain costs declined $87 million, consistent with its store-as-hub fulfillment strategy — though both improvements are largely captured and insufficient to close the structural cash flow gap.

What to Watch: Tracking Metrics and Valuation Reality

Five metrics will determine whether Target's FY2026 results confirm or falsify the capital return thesis:

1. Operating cash flow trajectory: Quarterly OCF annualizing above $7.1 billion (8%+ growth) would close the FCF-dividend gap even at $5 billion capex. Below $6.0 billion would widen it.
2. Capex run rate: Quarterly capex above $1.25 billion confirms the $5 billion pace. Below $1.1 billion suggests management is pulling back, creating FCF headroom.
3. Adjusted SG&A rate: Above 21.0% signals accelerating deleverage with no settlement to offset it. Below 20.5% would indicate the transformation program is delivering cost savings.
4. Comparable store sales: Two consecutive quarters of positive traffic would challenge the structural erosion thesis. Continued negative comps confirm the revenue headwind.
5. Debt issuance activity: New debt issuance specifically to fund operations or dividends (versus refinancing maturities) would confirm the "borrow and distribute" paradigm.

At $105.47, Target trades at 13.9x adjusted FY2025 earnings and 6.9x EV/EBITDA — the cheapest multiple in its peer group by a wide margin. The market is pricing in the quality concerns: Target is the only company in this comparison with negative revenue growth, the lowest FCF margin among retailers, and the only one whose dividend requires balance sheet funding at guided capex levels. The 4.3% dividend yield, while the highest in the group, compensates for a capital return model that is structurally more fragile than the 57-year streak implies.

The filing supports a real earnings floor — shrink recovery and fulfillment efficiency are genuine operational achievements. But the filing also documents a company whose adjusted operating income declined 14.2%, whose ROIC is falling while invested capital rises, and whose highest-margin products face concentrated tariff risk that management cannot quantify. At $105.47, the market implies sustainable adjusted earnings of roughly $7.57 per share. The filing supports that floor but complicates any thesis requiring earnings growth, because FY2026 must replace $1.01 per share in non-recurring settlement benefits while absorbing higher interest costs and an unquantified tariff headwind — all during a $5 billion reinvestment cycle generating declining returns on capital.

The thesis is falsified if Q1-Q2 FY2026 results show annualized OCF trending toward $7.1 billion or higher and capex tracking below the $5 billion guided pace. The earliest data point is Target's Q1 FY2026 earnings, expected June 2026.

Frequently Asked Questions

Is Target's dividend safe?

Target's 57-year dividend streak faces its most serious challenge. At the company's guided FY2026 capex of $5.0 billion, projected free cash flow of approximately $1.56 billion would fall $538 million below the ~$2.1 billion annual dividend. Target would need to draw on its $3 billion revolving credit facility or issue new debt to fund the dividend. The FCF payout ratio jumped from 46.4% to 73.9% in FY2025, and at guided capex it would exceed 100%. The dividend is likely safe for FY2026 given $5.5 billion in cash and a $3.0 billion revolver, but it is no longer self-funding from operations.

How does the $593M interchange settlement affect Target's actual earnings?

The $593 million interchange fee settlement reduced SG&A expenses, contributing approximately $1.01 per share in after-tax earnings. GAAP EPS was $8.13, but adjusted EPS excluding the settlement and $250M in transformation costs was $7.57 — a 6.9% difference. The settlement made the SG&A rate appear flat at 20.6% when the adjusted rate deteriorated 30 basis points to 20.9%. Adjusted operating income declined 14.2%, nearly twice the 8.1% GAAP decline. FY2026 has no comparable one-time benefit.

What is Target's tariff exposure?

Target's 10-K states approximately half of all merchandise is sourced internationally with China as the single largest source country. Owned brands represent approximately 30% of merchandise sales (~$31.4 billion) and carry higher import concentration than national brands. Target also uses a First Sale Declaration Program paying duties on the vendor's cost rather than the import price — if eliminated, duties would be assessed on a substantially higher cost basis. FY2026 guidance explicitly excludes tariff impacts.

How does Target's $5 billion capex plan affect free cash flow?

FY2025 capex of $3.73 billion already compressed FCF by 36.7% to $2.84 billion. The guided $5.0 billion for FY2026 would reduce FCF to approximately $1.56 billion at flat OCF — below the ~$2.1 billion dividend. The capex-to-depreciation ratio crossed 1.0x for the first time (0.97x to 1.19x), and the FY2026 guide implies approximately 1.6x, signaling a multi-year reinvestment super-cycle that will compress free cash flow through at least FY2027-2028.

What is Target's ROIC trend telling investors?

After-tax ROIC declined 160 basis points from 15.4% to 13.8% while average invested capital grew $1.19 billion to $30.4 billion. Target is investing more capital but generating lower returns. The filing does not disclose incremental ROIC on new investments, so investors cannot assess whether the $5 billion FY2026 capex program will generate returns above Target's estimated 8-9% WACC.

How does inventory shrink recovery affect Target's margins?

Target's filing discloses a shrink reserve sensitivity of approximately $110 million per 10% change, implying a total reserve of approximately $1.1 billion. The company reported shrink rates reaching pre-pandemic levels. This represents a genuine margin tailwind, but it is largely a one-time recovery that cannot recur. The exact dollar benefit is not disclosed in the filing.

How does Target compare to Lowe's and other peers?

Among peers (LOW, CVS, SBUX, SHW), Target has the only negative revenue growth (-1.7% vs LOW's +0.6%), the lowest FCF margin among retailers (2.7% vs LOW's 8.4%), and the only FCF-below-dividend situation. Target's EV/EBITDA of 6.9x is the lowest in the group, reflecting quality concerns. On the positive side, Target offers the highest dividend yield (4.3%) and strongest interest coverage (11.5x).

What is the First Sale Declaration Program?

The First Sale Declaration Program allows Target to pay import duties based on the vendor's manufacturing cost rather than Target's higher purchase price. The 10-K warns duties could rise substantially if the U.S. government eliminates this methodology. For a company sourcing approximately half its merchandise internationally, the difference between vendor cost and import cost across the full supply chain could represent hundreds of millions in additional duty exposure.

What would prove the bearish dividend thesis wrong?

The thesis would be falsified if FY2026 operating cash flow grows 8%+ to approximately $7.1 billion, closing the FCF-dividend gap even at $5 billion capex. Alternatively, if actual capex comes in below $4.5 billion, or if meaningful working capital improvement generates $500 million+ in incremental cash. The earliest testable data point is Target's Q1 FY2026 earnings, expected June 2026.

Is Target a value trap at $105?

At $105.47, Target trades at 6.9x EV/EBITDA and 13.9x adjusted earnings. The filing reveals FCF margin compressed to 2.7%, ROIC declined 160 bps, and the capital return model now requires external financing. If incremental ROIC on the $5 billion capex program exceeds WACC (~8-9%), the reinvestment creates long-term value despite short-term pain. If incremental ROIC is below WACC — and the filing provides no data to test this — Target is destroying value, and the dividend faces growing risk.

How reliable is Target's FY2026 earnings guidance?

Management guides FY2026 EPS of $7.50-$8.50, but FY2025 results missed the prior year's cautiously optimistic guidance — revenue declined 1.7% instead of the expected positive comp growth. The FY2026 guide excludes tariff impacts, excludes potential additional transformation costs, and has no one-time settlement comparable to FY2025's $593 million. At the midpoint ($8.00), Target needs approximately $1.01/share of organic improvement just to replace the interchange settlement before delivering further growth.

What are Target's debt maturity risks?

Target has $2.13 billion maturing within 12 months, up 30% from $1.64 billion. Total gross debt increased $494 million to $14.4 billion despite the deleveraging narrative. As cheap legacy debt (2.9% average rate, 2026-2030 bucket) rolls off and is replaced at 4.5-5.0%, incremental annual interest expense is estimated at $80-103 million. Target maintains $5.5 billion in cash and a $3.0 billion undrawn revolver expiring October 2028.

Methodology

Data Sources

This analysis is based on Target Corporation's FY2025 Annual Report (10-K filed March 11, 2026) covering the fiscal year ended January 31, 2026. Financial metrics were extracted and calculated using the MetricDuck automated pipeline, which processes XBRL-tagged data from SEC EDGAR filings. Peer comparison data (CVS, SHW, SBUX, LOW) was sourced from each company's most recent fiscal period filings via the same pipeline. Market data (stock price, EV/EBITDA, dividend yield) reflects values as of the analysis date.

Limitations

• Projected FY2026 figures assume flat operating cash flow. If OCF grows or contracts from $6.56 billion, the FCF-dividend gap projection changes accordingly. This is a scenario analysis, not a forecast.
• Tariff impact is unquantifiable from the filing. The First Sale Declaration Program exposure and total tariff cost are disclosed as risks but not quantified. Any estimate of dollar impact would require assumptions not supported by filing data.
• Shrink reserve estimate is derived, not disclosed. The $1.1 billion figure is inferred from the $110 million / 10% sensitivity disclosure. Target does not separately report the shrink reserve balance.
• Incremental ROIC is not testable. The filing discloses aggregate ROIC (13.8%) but provides no data on returns from the $5 billion FY2026 capex program specifically.
• Peer comparisons have structural limitations. SBUX and LOW ROIC figures are distorted by negative shareholder equity; CVS gross margin reflects PBM pass-through accounting; SHW EV/EBITDA reflects fiscal period composition anomalies. These metrics are excluded from prose comparisons.
• Adjusted operating income is a derived figure. The $4,774M adjusted OI and 14.2% decline are calculated from disclosed GAAP figures minus the $593M settlement plus the $250M transformation costs. Target does not report this exact adjusted figure.

Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. The author does not hold positions in TGT, CVS, SHW, SBUX, or LOW. Past performance and current metrics do not guarantee future results. All data is derived from public SEC filings and may contain errors or omissions from the automated extraction process.